5P01HD029587-22 |
2016 |
$131196 |
7044 |
PROJECT 1 - MOLECULAR ANALYSIS OF NMDA RECEPTOR MODULATORY SITES |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE |
5P01HD029587-22 |
2016 |
$439248 |
7045 |
PROJECT II - CLINICALLY-SAFE NMDAR ANTAGONISTS PREVENT NEUROTOXICITY |
SCINTILLON INSTITUTE FOR PHOTOBIOLOGY |
5P01HD029587-20 |
2015 |
$125882 |
7044 |
PROJECT 1 - MOLECULAR ANALYSIS OF NMDA RECEPTOR MODULATORY SITES |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE |
7P01HD029587-21 |
2015 |
$147264 |
7044 |
PROJECT 1 - MOLECULAR ANALYSIS OF NMDA RECEPTOR MODULATORY SITES |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE |
5P01HD029587-20 |
2015 |
$136387 |
7045 |
PROJECT II - CLINICALLY-SAFE NMDAR ANTAGONISTS PREVENT NEUROTOXICITY |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE |
7P01HD029587-21 |
2015 |
$269113 |
7045 |
PROJECT II - CLINICALLY-SAFE NMDAR ANTAGONISTS PREVENT NEUROTOXICITY |
SCINTILLON INSTITUTE FOR PHOTOBIOLOGY |
5P01HD029587-19 |
2014 |
$371120 |
7044 |
PROJECT 1 - MOLECULAR ANALYSIS OF NMDA RECEPTOR MODULATORY SITES |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE |
5P01HD029587-19 |
2014 |
$402170 |
None |
PROJECT II - CLINICALLY-SAFE NMDAR ANTAGONISTS PREVENT NEUROTOXICITY |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE |
5P01HD029587-18 |
2013 |
$418604 |
7044 |
PROJECT 1 - MOLECULAR ANALYSIS OF NMDA RECEPTOR MODULATORY SITES |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE |
5P01HD029587-18 |
2013 |
$381403 |
7045 |
PROJECT II - CLINICALLY-SAFE NMDAR ANTAGONISTS PREVENT NEUROTOXICITY |
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE |